Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1986 May;41(5):376–380. doi: 10.1136/thx.41.5.376

Human tumour xenografts growing in immunodeficient mice: a useful model for assessing chemotherapeutic agents in bronchial carcinoma.

R J Fergusson, J Carmichael, J F Smyth
PMCID: PMC1020631  PMID: 3750245

Abstract

Xenografts from eight human bronchial carcinomas have been established in CBA/Lac mice rendered immunodeficient by neonatal thymectomy followed three weeks later by whole body irradiation (7.35 Gy (735 rads)) after a priming dose of cytosine arabinoside. Growth rates of individual tumour lines remain constant and the histological and chromosomal characteristics of the original tumour are maintained through multiple serial passages over many months. With specific growth delay as the principal end point this system may be used to assess the response of histologically different lung tumours to chemotherapeutic agents.

Full text

PDF
376

Images in this article

378Image
on p.378

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMBROSE E. J., ANDREWS R. D., EASTY D. M., FIELD E. O., WYLIE J. A. Drug assays on cultures of human tumour biopsies. Lancet. 1962 Jan 6;1(7219):24–25. doi: 10.1016/s0140-6736(62)92645-4. [DOI] [PubMed] [Google Scholar]
  2. Bailey M. J., Gazet J. C., Peckham M. J. Human breast-cancer xenografts in immune-suppressed mice. Br J Cancer. 1980 Oct;42(4):524–529. doi: 10.1038/bjc.1980.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Courtenay V. D., Mills J. An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. Br J Cancer. 1978 Feb;37(2):261–268. doi: 10.1038/bjc.1978.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hamburger A. W., Salmon S. E. Primary bioassay of human tumor stem cells. Science. 1977 Jul 29;197(4302):461–463. doi: 10.1126/science.560061. [DOI] [PubMed] [Google Scholar]
  5. Hay J. H., Morten J. E., Clarke B., Swinton J. The suitability of immunosuppressed mice kept in a standard animal unit as recipients of human tumour xenografts. Lab Anim. 1985 Apr;19(2):119–122. doi: 10.1258/002367785780942561. [DOI] [PubMed] [Google Scholar]
  6. Kopper L., Steel G. G. The therapeutic response of three human tumor lines maintained in immune-suppressed mice. Cancer Res. 1975 Oct;35(10):2704–2713. [PubMed] [Google Scholar]
  7. Mattern J., Jäger S., Sonka J., Wayss K., Volm M. Growth of human bronchial carcinomas in nude mice. Br J Cancer. 1985 Feb;51(2):195–200. doi: 10.1038/bjc.1985.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Millar J. L., Blackett N. M., Hudspith B. N. Enhanced post-irradiation recovery of the haemopoietic system in animals pretreated with a variety of cytotoxic agents. Cell Tissue Kinet. 1978 Sep;11(5):543–553. doi: 10.1111/j.1365-2184.1978.tb00826.x. [DOI] [PubMed] [Google Scholar]
  9. Nowak K., Peckham M. J., Steel G. G. Variation in response of xenografts of colo-rectal carcinoma to chemotherapy. Br J Cancer. 1978 Apr;37(4):576–584. doi: 10.1038/bjc.1978.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rygaard J., Povlsen C. O. Heterotransplantation of a human malignant tumour to "Nude" mice. Acta Pathol Microbiol Scand. 1969;77(4):758–760. doi: 10.1111/j.1699-0463.1969.tb04520.x. [DOI] [PubMed] [Google Scholar]
  11. Selby P. J., Courtenay V. D., McElwain T. J., Peckham M. J., Steel G. G. Colony growth and clonogenic cell survival in human melanoma xenografts treated with chemotherapy. Br J Cancer. 1980 Sep;42(3):438–447. doi: 10.1038/bjc.1980.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Shimosato Y., Kameya T., Nagai K., Hirohashi S., Koide T., Hayashi H., Nomura T. Transplantation of human tumors in nude mice. J Natl Cancer Inst. 1976 Jun;56(6):1251–1260. doi: 10.1093/jnci/56.6.1251. [DOI] [PubMed] [Google Scholar]
  13. Shorthouse A. J., Peckham M. J., Smyth J. F., Steel G. G. The therapeutic response of bronchial carcinoma xenografts: a direct patient-xenograft comparison. Br J Cancer Suppl. 1980 Apr;4:142–145. [PMC free article] [PubMed] [Google Scholar]
  14. Shorthouse A. J., Smyth J. F., Steel G. G., Ellison M., Mills J., Peckham M. J. The human tumour xenograft--a valid model in experimental chemotherapy? Br J Surg. 1980 Oct;67(10):715–722. doi: 10.1002/bjs.1800671011. [DOI] [PubMed] [Google Scholar]
  15. Spiro S. G. Chemotherapy for small cell lung cancer. Br Med J (Clin Res Ed) 1985 Feb 9;290(6466):413–414. doi: 10.1136/bmj.290.6466.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Steel G. G., Courtenay V. D., Peckham M. J. The response to chemotherapy of a variety of human tumour xenografts. Br J Cancer. 1983 Jan;47(1):1–13. doi: 10.1038/bjc.1983.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Steel G. G., Courtenay V. D., Rostom A. Y. Improved immune-suppression techniques for the exongrafting of human tumours. Br J Cancer. 1978 Feb;37(2):224–230. doi: 10.1038/bjc.1978.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. WRIGHT J. C., COBB J. P., GUMPORT S. L., GOLOMB F. M., SAFADI D. Investigation of the relation between clinical and tissue-culture response to chemotherapeutic agents on human cancer. N Engl J Med. 1957 Dec 19;257(25):1207–1211. doi: 10.1056/NEJM195712192572502. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES